Crossmark

Correction to: The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome

Crossref DOI link: https://doi.org/10.1038/s41388-021-02164-y

Published Online: 2022-01-20

Published Print: 2022-02-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rugolo, Francesco https://orcid.org/0000-0002-3174-100X
Bazan, Nicolas G. https://orcid.org/0000-0002-9243-5444
Calandria, Jorgelina https://orcid.org/0000-0002-8995-0621
Jun, Bokkyoo

Raschellà, Giuseppe https://orcid.org/0000-0002-6070-577X
Melino, Gerry https://orcid.org/0000-0001-9428-5972
Agostini, Massimiliano https://orcid.org/0000-0003-3124-2072
License Information

Text and Data Mining valid from 2022-01-20

Version of Record valid from 2022-01-20
More Information

Article History

First Online: 20 January 2022

Free to read: This content has been made available to all.